Epidemiological Tools that Predict Partial Herd Immunity to SARS Coronavirus 2
Preprint
Abstract
SUMMARY: The outbreak of SARS coronavirus 2 (SARS-CoV-2), which occurred in Wuhan, China in December 2019, has caused a worldwide pandemic of coronavirus disease 2019 (COVID-19). However, there is a lack of epidemiological tools to guide effective public policy development. Here we present epidemiological evidence that SARS-CoV-2 S type exited Wuhan or other epicenters in China earlier than L type and conferred partial resistance to the virus on infected populations. Analysis of regional disparities in incidence has revealed that a sharp decline in influenza epidemics is a useful surrogate indicator for the undocumented spread of SARS-CoV-2. The biggest concern in the world is knowing when herd immunity has been achieved and scheduling a time to regain the living activities of each country. This study provides a useful tool to guide the development of local policies to contain the virus.Keywords
This publication has 12 references indexed in Scilit:
- Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in ChinaJAMA, 2020
- Estimation of the asymptomatic ratio of novel coronavirus infections (COVID-19)International Journal of Infectious Diseases, 2020
- Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral sheddingNature Medicine, 2020
- On the origin and continuing evolution of SARS-CoV-2National Science Review, 2020
- A Novel Coronavirus from Patients with Pneumonia in China, 2019New England Journal of Medicine, 2020
- Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (COVID-19)medRxiv, 2020
- Estimation of the asymptomatic ratio of novel coronavirus infections (COVID-19)medRxiv, 2020
- A new coronavirus associated with human respiratory disease in ChinaNature, 2020
- A pneumonia outbreak associated with a new coronavirus of probable bat originNature, 2020
- A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family clusterThe Lancet, 2020